Localize ads

You shipped a product update last week. Your domestic users got the new onboarding flow. Your French users got last quarter's version. Your Spanish users got something in between. This is content drift — and it's one of the most common and least visible localization failures in B2B software. Manual file handoffs, disconnected workflows, and translation pipelines that run behind the product cycle mean your multilingual experience is always slightly out of date. For companies selling software to other companies, that gap is a product quality problem your customers will notice before you do. Here's what's causing it — and how leading teams are fixing it.

Global campaigns don’t break at the strategy level. They break in the handoffs. Marketing finishes the work, translations are complete, and then everything stalls waiting on a developer. It happens on every update, every launch, every market. And over time, that dependency becomes the biggest constraint on growth.

When a health system or payer evaluates your platform, their security and compliance team reviews more than your SOC 2. They want to know how you handle PHI when content gets translated. Whether your translation vendor has a BAA in place. Whether there's an audit trail if something goes wrong. Most B2B Healthtech platforms can't answer those questions cleanly — because localization was built as a content workflow, not a compliance one. OneStudyTeam localized a multi-site clinical trial platform without ever exposing patient data — with PHI/PII exclusion controls, BAA coverage, and full audit trails baked into the process. Here's how they did it.

Most AI translation decisions are made once — pick an engine, configure it, assume it'll improve over time. That assumption no longer holds. Localize ran two independent blind studies in 2025, evaluating 9 leading AI translation engines across 6 languages and multiple content types. The findings reveal that AI translation quality is dynamic, uneven, and highly dependent on language and content type. For product teams building B2B software, the implications are significant. Read what we found.

The enterprise health systems and payers writing the biggest Healthtech contracts serve workforces and patient populations that speak dozens of languages. They're starting to require multilingual platform support — not as a nice-to-have, but as a procurement criterion. Most B2B Healthtech platforms are behind on this. The ones that aren't are winning deals their competitors don't even understand they lost. A major US hospital network needed a multilingual content infrastructure that could scale without doubling its content team. Here's what they built — and what it unlocked.

Global expansion is easy to say. But execution gets complicated fast. Every new language adds more work, more dependencies, and more chances for things to break. Most teams aren’t built for that level of coordination and it shows up as slower launches, inconsistent messaging, and stalled campaigns.